WO1997038116A1

WO1997038116A1 - The use of dna sequences for male sterility in transgenic plants

Info

Publication number: WO1997038116A1
Application number: PCT/GB1997/000992
Authority: WO
Inventors: Roderick John Scott; Wyatt Paul; Pascual Perez
Original assignee: Gene Shears Pty. Limited
Priority date: 1996-04-11
Filing date: 1997-04-10
Publication date: 1997-10-16
Also published as: US7345222B1; AU733870B2; GB9607517D0; AU2515197A; EP0906436A1; DE69738925D1; ATE405657T1; EP0906436B1; ES2308786T3; JP2000508166A; PT906436E; CA2250942A1

Abstract

The use of DNA sequences comprising a glucanase coding region operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence with appropriate tissue and/or temporal specificity, in the preparation of a male sterile transgenic tomato plant is disclosed. In preferred embodiments the promoter is a tapetum specific promoter, e.g. an A3 or an A9 promoter. DNA sequences comprising the PR-Glucanase coding region and an A3 or an A9 promoter, preferably an A9 promoter are also described, as are transgenic tomato plants, plant cells, propagating material, seeds, antisense DNA sequences and ribozyme encoding DNA sequences for restoration of male fertility.

Description

THE USE OF DNA SEQUENCES FOR MALE STERILITY IN TRANSGENIC PLANTS

The present mvencion relates to the use of DNA sequences comprising the coding sequence for a Glucanase enzyme, particularly PR-Glucanase, operably linked to a promoter having an appropriate temporal and/or tissue expression pattern, for instance a tapetum specific promoter, eg an A3 or A9 promoter to transform tomato plants or plant cells to generate male-sterile tomato plants. Tomato plants, and seeds thereof, also form part of the invention.

Hybrid plants have the advantages of higher yield and better disease resistance than their parents, because of heterosis or hybrid vigour. Crop uniformity is another advantage of hybrid plants when the parents are extensively homozygous; this leads to improved crop management. Hybrid seed is therefore commercially important and sells at a premium price.

To date there have been various proposals relating to the production of male-sterile plants. EP-A-0329308 describes various methods for producing male-sterile plants including the use of DNA sequences which code for "antisense" RNA which can block expression of one or more genes essential for pollen production as well as the use of a pollen specific promoter to drive expression of a DNA sequence coding for a cytotoxic molecule.

EP-A-0344029 similarly describes methods for producing male-sterile plants which are based on the use of "antisense" DNA sequences as well as the use of tissue specific promoters to control expression of a cytotoxic molecule. Examples of such cytotoxic molecules provided in EP-A-0344029 are RNase Tl, Barnase, DNases, proteases, phytohormones, enzymes involved in the synthesis of auxin, glucanases, lipases, lipid peroxidases, plant cell wall inhibitors and bacterial toxins.

Methods which rely on the expression of a cytotoxic substance in particular tissues are, of course, dependent upon the availability of tissue specific promoters. WO-A- 92/11379 provides certain Tapetum-specific promoters, designated A3 and A9 which are useful in*methods for the production of male-sterile plants by means of tissue and temporal specific expression of a cytotoxic substance.

Barnase in particular has been put forward as a particularly useful cytotoxic molecule for use in producing male-sterile plants. However, Barnase does not appear to be useful in all plant species. In particular it has now been found to have certain side effects in Tomato plants which have been transformed with a DNA molecule comprising a Barnase coding sequence under the control of a tissue specific promoter. Thus, at present there is is no useful method for the production of male- sterile Tomato plants.

Surprisingly, we have now found that in the case of tomato plants the use of, for example, a tapetum specific promoter to drive expression of a DNA sequence encoding a glucanase enzyme does represent a particularly effective method of producing male-sterile tomato plants which avoids the side effect problems experienced with

Barnase. Examples of useful tapetum specific promoters include the A3 or A9 promoters described in WO-A- 92/11379. Thus, in a first aspect, the present invention provides the use of:

(i) a DNA sequence comprising the coding sequence of a glucanase enzyme;

(ii) a DNA sequence substantially homologous to a DNA sequence as defined in (i) ; or

(iii) a DNA sequence coding for a protein substantially homologous to the glucanase as defined in (i) or (ii) ;

operably linked to a promoter, or other regulatory sequence, which provides expression of the DNA sequence with appropriate tissue and/or temporal specificity, in the preparation of a male sterile transgenic tomato plant .

In the context of the present invention, "appropriate tissue and/or temporal specificity" means that the promoter provides for exression of the glucanase in such a way that male sterility results in the transgenic tomato plant. For example, the sequence will be expressed in tissues where its activity will lead to male sterility. Time of expression may also be important and hence the need for a degree of temporal specificity.

Suitably, the DNA sequence will be operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence in the tapetum and/or microsporogenous cells prior to expression of callase . Thus, tapetum specific promoters with appropriate temporal expression paterns are particularly useful, eg an A3 or an A9 promoter as disclosed in WO-A-92/11379 , as well as sequences which consist only of those regulatory elements from such promoters wnich are required to initiate tissue specific expression.

Additionally, promoters which have desired temporal specificity but which are more generally expressed throughout plant tissue may also be useful m the practice of the present invention, provided that they are active in the appropriate tissues, and hence the use of such promoter sequences are also within the scope of the invention.

In the case of (i) as defined above the coding sequence for the glucanase enzyme will be the natural coding sequence. For sequences as defined n (ii) above, it is a sequence substantially homologous to the natural coding sequence. The skilled man will appreciate that due to the degeneracy of the genetic code it is possible to make conservative changes to the DNA sequence which w ll not result m changes to the ammo acid sequence of the glucanase enzyme. In addition, sequences defined m (m) above are also within the scope of the invention. It is well known in the protein art that "conservative" or indeed "semi-conservative" changes can be made to the ammo acid sequence of a protein which will not alter ts fundamental activity. For example, ammo acids such as glycine, valme, leucine and isoleuc e, which all have aliphatic side chains, may often be substituted for each other without substantially altering the biological activity of the protein. Similarly, ammo acids such as phenylalan e, tyrosine and tryptophan, which all have aromatic side chains, may be substituted for each other. Thus, the use of DNA sequences coding for such modified forms of the glucanase enzyme are also within the scope of the present invention.

In the context of (iii) as defined above, the proteins coded for by the DNA sequence which are substantially homologous to the glucanase protein as defined in (i) or

(ii) above, may be 40%, 50%, 60%, 70%, 80%, 90%, 95% or even 99% homologous. Preferably, the protein will be 60% homologous, more preferably 80% homologous, even more preferably 90% homologous and most preferably 95% homologous .

In the context of the present invention, the term "promoter, or other regulatory sequence" includes the complete promoter sequence eg the A3 or A9 promoter, or may refer to those elements or parts of the promoter sequence which provide the necessary tissue and/or temporal specificity. Thus, the skilled man would understand that a complete promoter sequence could be so modified to remove non-essential, non-regulatory elements if required. In addition, it would be possible to modify constitutive promoters by inclusion of tissue and/or temporal control sequences from promoters such as the A3 or A9 promoters to produce composite or chimeric promoter sequences useful in the practice of the invention.

As mentioned above, examples of suitable tapetum specific promoters include the A3 and A9 promoters. In addition, it will also be understood by the skilled man that such A3 or A9 promoters can be derived not only from Brassicaceae spp as disclosed in WO-A-92/11379, but also from other sources, for instance from Maize. Thus, the use of A3 or A9 "like" promoters derived from such other sources, eg the A9 "like" promoter from Maize also form part of the present invention.

In a preferred embodiment, the promoter will be either the complete A9 promoter or at least those regulatory elements essential for initiation of transcription. In particular the A9 promoter from Brassicaceae spp . is preferred. One example of a preferred glucanase enzyme whose DNA coding sequence is useful in the present invention is β(1, 3) PR-Glucanase. A DNA sequence encoding this enzyme is shown in figure 5.

DNA for use in accordance with the invention may be in the form of a vector. Examples of suitable vectors include plasmids, cosmids, artificial chromosomes, viruses or phages. In addition, DNA sequences used in the invention may include one or more selectable markers to enable selection of cells transfected (or transformed: the terms are used interchangeably in this specification) with them and, preferably, to enable selection of cells harbouring vectors incorporating heterologous DNA. One example of such a selectable marker is a gene which when expressed will confer herbicide reistance, eg a gene conferring resistance against the herbicide BASTA.

Although EP-A-0344029 included glucanases as an example of cytotoxic molecules for use in conferring male sterility, this was disclosed only as part of a general list of possibilities of apparently equal merit, and this disclosure did not include any discussion of the particular problems associated with producing a useable male sterile tomato plant.

O-A-92/11379 disclosed DNA constructs comprising the A3 or A9 promoter from Brassicaceae and the coding sequence for _/S-1,3 glucanase from N. tabacum . However, this disclosure also included examples using the A3 or A9 promoter to drive expression of Barnase, and again no discussion of the particular advantages of using an A3/A9-glucanase system in a tomato plant was disclosed.

DNA for use in accordance with the invention can be prepared by any convenient method involving coupling together successive nucleotides, and/or ligating oligo- and/or poly-nucleotides, including in vi tro processes, but recombinant DNA technology forms the method of choice. Ultimately, the DNA will be introduced into plant cells, by any suitable means.

Preferably, plant cells are transformed with DNA using a disarmed Ti-plasmid vector and carried by Agrobacterium by procedures known in the art, for example as described in EP-A-0116718 and EP-A-0270822. Alternatively, the foreign DNA could be introduced directly mto plant cells usmg an electrical discharge apparatus. Any other method that provides for the stable incorporation of the DNA withm the nuclear DNA of any plant cell of any species would also be suitable.

Although the provision of male-sterile plants is advantageous, there is also a need to provide a means for the restoration of fertility. One may wish to ensure, for instance, that 100% of Fl hybrid plants are fertile. A convenient way to achieve this is by the use of a restorer gene or sequence. In the context of the present invention this restorer gene can comprise DNA encoding RNA which is in the antisense orientation relative to the RNA transcribed from the glucanase DNA sequence. This restorer DNA can be operably linked to a promoter which displays an appropriate temporal and tissue expression pattern, eg that used to drive expression of the glucanase DNA sequence as described above. Thus, promoters, or other regulatory sequences as described herein are equally useful in providing for restoration of male fertility. Thus, it can be operably linked to a tapetum specific promoter such as an A3 or A9 promoter as described herein.

In a second aspect, therefore, the present invention provides the a DNA sequence which is complementary to at least part of a DNA sequence coding for a glucanase as defined in d) , ( i) or (iii) above. Suitably, the DNA sequence of this aspect of the invention is operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence with appropriate tissue and/or temporal specificity. In preferred embodiments, the promoter, or other regulatory sequence, will be as described above for use with the glucanase encoding DNA sequence.

Suitably, the antisense DNA sequence is complementary to at least a part of the DNA sequence encoding PR- Glucanase, eg is complementary to at least part of the sequence shown figure 5.

A still further example of fertility restorer DNA encodes an RNA enzyme (known as a ribozyme) capable of highly specific cleavage against a given target sequence (Haseloff and Gerlach Na ture 334 585-591 (1988)) . Like antisense DNA, for ribozyme DNA (coding in this instance for a ribozyme which is targeted against the RNA encoded by a glucanase coding sequence) it may be possible to use any appropriate promoter, or other regulatory sequence as described herein to drive ribozyme-encoding DNA.

Thus, according to a third aspect of the invention, there is provided a DNA sequence encoding a ribozyme capaυle of specific cleavage of RNA encoded by a DNA molecule as defined in (1) , (11) or (m) as described herein. Suitably, the ribozyme encoding DNA sequence can be under the control of a promoter, or other regulatory sequence, which provides for expression of the ribozyme encoding DNA sequence with appropriate tissue and/or temporal specificity, eg a tapetum specific promoter such as an A3 or an A9 promoter, preferably an A9 promoter. In a preferred embodiment the ribozyme is capable of specifically cleaving RNA derived from a DNA sequence coding for PR-Glucanase. A suitable ribozyme coding DNA sequence is shown figure 9.

The present invention contemplates the use of all forms of ribozyme. These include ribozymes as described by Haseloff and Gerlach (Na ture, 334:585-591 (1988) ) , ribozymes which form part of an expressed message, ribozymes which are embedded within snRNA or tRNA and multimeric ribozymes, which in turn can be comprised of the same or different individual ribozymes .

Both the complementary DNA sequences of the invention as well as the ribozyme-encodmg DNA of the invention would be useful in restoring male fertility in tomato plants. Thus, in a fourth aspect, the present invention provides the use of such DNA sequences of the invention m the restoration of male-fertility in a tomato plant.

Thus, the use of the glucanase encoding DNA sequences as defined herein enables the production of transgenic tomato plants which are male-sterile. Thus, m a fifth aspect, the present invention provides a transgenic tomato plant whicn has incorporated at least some of its cells a glucanase encoding DNA sequence as defined herem and as described above.

In a sixth aspect, the present invention provides a transgenic tomato plant which has incorporated m at least some of its cells a complementary or ribozyme encoding DNA sequence of the mvention.

In further aspeacts the present invention provides:

(i) a plant cell including a glucanase encoding DNA sequence of the invention;

(ii) a plant cell including a complementary or ribozyme encoding DNA sequence of the invention;

(in) propagating material derived from a transgenic plant of the invention;

(iv) seeds obtainable from a transgenic plant of the invention; and

(v) a method for restoring male fertility a male-sterile tomato plant which comprises:

d) producing a male-sterile transgenic tomato plant of the invention; and

(ii) crossing the transgenic tomato plant produced step d) with a transgenic tomato plant of the invention which has incorporated in at least some of its cells a complementary or ribozyme encoding DNA sequence of the invention.

Preferred features of each aspect of the invention are as for each other aspect mutatis mutandis .

The invention will now be described with reference to the following examples, which should not be construed as in any way limiting the invention. The examples refer to the figures in which:

Figure 1: is a schematic diagram of plasmids pWP173GA and pWP174GA;

Figure 2: shows the phenotype of A9-PR-Glucanase ( P173GA) tomato plants: A) Wild-type tetrads stained with Aniline Blue for callose; B) A9-PR Glucanase tetrads stained with Aniline B l u e ; callose surrounding tetrads has been degraded by

PR-Glucanase; C) Wild-type mature pollen D) PR- Glucanase plant lacks mature pollen but has tetrad-like fused microspores at anther dehiscence; E) A9-PR-Glucanase plant; the first two flowers on the truss have been cross-pollinated with wild-type pollen; F) Section of cross-pollinated derived fruit from an A9 PR-Glucanase plant hybrid seed can be seen; G) Parthenocarpic fruit on a non-cross pollinated A9 PR Glucanase plant; this fruit has no seed. H) Wild-type segregant from an A9 PR

Glucanase plant line; this exhibits normal fruit set ;

Figure 3: shows floral morphology of wild-type tomato plants and male sterile WP173GA and WP174GA plants; the A9-Barnase plants have flowers that are reduced in size compared to wild-type and A9-PR Glucanase plants;

Figure 4: shows the molecular analysis of 15 transgenic tomatoes carrying A9-PR glucanase and Basta resistance genes;

Figure 5: shows the sequence of the PR-Glucanase gene. Regions that are underlined are complementary n sequence to the arms of the ribozymes described in Example 6;

Figure 6 : is a schematic diagram showing the antisense (filled boxes) and partial sense (open boxes) PR-Glucanase fragments cloned behind the A9-promoter; the number and proportion of tobacco retransformants that lacked detectable PR-Glucanase protein, as determined by Western analysis, is indicated;

Figure 7 : shows Western analysis of PR-Glucanase protein levels in anthers (from buds of 8-l0mm in length) of progeny of a male-fertile (restored) tobacco plant transformed with the A9-antisense PR-Glucanase construct, pJSHIA; the genotype of the tobacco plants is indicated above each lane; plants containing the A9 - PR Glucanase gene but not the A9 -antisense PR-Glucanase gene contam PR-Glucanase protein in anthers (arrowed) ; plants containing both the A9 - PR Glucanase and A9 antisense PR-Glucanase genes lack the PR-Glucanase protein; antibody a gift from Pierre De Wit (raised against tomato acidic β-1, 3-glucanase) ;

Figure 8: shows schematic diagrams of (A) 35S-Ac plasmid pBI0S144, (B) A9-PR - Glucanase antisense and (C) A9-PR-Glucanase partial sense plasmids used to transform tomato;

Figure 9 : shows the DNA sequence of the multimeric ribozyme; the adenosine residue (lower case) at position 15 of the catalytic unit of ribozyme 4 is missing in the final multimeric ribozyme;

Figure 10: shows in vi tro activity of the multimeric ribozyme at 50°C and at 22°C; the sizes and origins of the various cleavage products are indicated to the left of the gel; no cleavage products that result from ribozyme cleavage at site 4 can be seen;

Figure 11: is a schematic diagram of A9-multimeric ribozyme plasmids used to transform tobacco (A) and tomato (B) ; and

Figure 12: Western analysis of PR-Glucanase protein levels in anthers (from buds of 8-10mm in length) of progeny of a male-fertile (restored) tobacco plant transformed with the A9-ribozyme construct, p3039; plants containing both the A9 - PR Glucanase and A9 multimeric ribozyme genes lack the

PR-Glucanase protein (arrowed) . EXAMPLE 1: Comparison of the phenotype of A9 promoter -PR Glucanase tomato plants with A9 promoter Barnase tomato plants

When transformed into the model plant species tobacco, both the A9 promoter - Barnase and A9 promoter- PR glucanase chimaeric genes will cause male sterility (Paul et al , Plant Molecular Biology, 19:611-622 (1992) ; Worrall et al , Plant Cell , 4:759-771 (1992)) . In the case of A9-Barnase, the majority of the male sterile plants were phenotypically normal. To determine which AMS gene is superior in the closely related species tomato, both AMS genes were transferred into a binary vector that is preferred for tomato transformation. This binary vector, pGA492 (An, Plant Physiology, 81:86-91 (1986) ) , gives a higher number of tomato transformants than the vector pBinl9 (Bevan et al, Nucl . Acids Res . , 12:8711-8721

(1984)) which was used in previous experiments in tobacco.

First the Kpnl, EcoKV A9-PR Glucanase chimaeric gene fragment of pDW80PR (Worrall et al (1992) supra) was cloned between the Kpnl and S al sites of pBluescript KS+ (Stratagene) forming pWP173. Secondly the A9-PR Glucanase gene of pWP173 was transferred as a Kpnl, SstI fragment into Kpnl, SstI - cut pGA492 forming pWP173GA (Figurel) .

Similarly the Kpnl, EcoRV A9-Barnase chimaeric gene fragment of pWP127 (Paul et al (1992) supra) was cloned between the Kpnl and Smal sites of pBluescript KS+ forming pWP174. The A9 -Barnase gene was then transferred from pWP174 as a Kpnl-SstI fragment into Kpnl, SstI - cut pGA492 forming pWP174GA (Figure 1) . Both plasmids were then transferred to Agrobacteria which was then used to transform tomato and the primary transformants scored for male fertility.

Of 31 tomato plants transformed with the PR-Glucanase gene, 26 plants exhibited complete male sterility with no observable pleiotropic effects (Figure 2) . Progeny of primary transformants, which contained a single copy of the A9-PR Glucanase gene, were analysed and shown to be completely male sterile if they inherited the A9-PR Glucanase gene.

Of 29 tomato plants transformed with the A9-Barnase gene only 11 exhibited male sterility. However 50% of the male sterile plants also exhibited additional pleiotropic effects including stunted growth with small and malformed flowers (Figure 3) . These additional phenotypes are likely to be due to inappropriate expression of Barnase, perhaps due to the influence of flanking plant DNA sequences. Although some A9-Barnase plants were male sterile without obvious additional phenotypes there is a possibility that such plants may also inappropriately express Barnase in certain environmental conditions.

Thus the A9-PR-Glucanase gene is preferred for the creation of male sterile tomato plants.

EXAMPLE 2 : inkage of the A9-Glucanase chimaeric gene to BASTA resistance and field trials

In dominant male sterility systems the AMS plants are maintained by pollination with wild type plants . Seed produced on the AMS plant will therefore a 1:1 mixture of AMS and wild-type plants. To select for tomato seedlings that contain the AMS gene, the A9-PR glucanase gene is linked to the herbicide resistance gene phosphmothricin acetyl transferase, PAT (Wohlleben et al , Gene , 70:25-37 (1988)) which confers resistance to the herbicide BASTA. A 1.6 kb Kpnl fragment encoding the CaMV 35S promoter-PAT chimaeric gene from pBASTA (a derivative of pIB16.1 (Broer et al , In proceedings of the Braunschweig Symposium on Applied Plant Molecular Biology, Braunschweig, Novenber 21-23 (1989) pp240-246) was cloned into the Kpnl site of pWP173GA forming pBIOS171 (Figure 4) . pBIOS171 was transformed into tomato (Figure 4) . Of 21 primary transformants 16 were male sterile. In progeny of plants containing a single copy of the BASTA- A9-PR glucanase gene, BASTA resistance co-segregated with male sterility. A field trial of 4 male sterile lines demonstrated that complete male sterility was maintained over a flowering period of 90 days (at which point the trial was terminated) .

EXAMPLE 3 : Evaluation of male fertility restoration genes in tobacco: A9 promoter PR-Glucanase antisense and partial sense chimaeric genes

In order for 100% of Fl hybrid plants to be male fertile, the male parent used in the hybrid cross must be homozygous for a gene, a restorer gene, that will neutralize the effect of the A9-PR-Glucanase gene. An example of such a restorer gene is an A9-promoter antisense PR-Glucanase gene. The use of the A9 promoter to drive the expression of the restorer gene is preferred, though any promoter having a suitable temporal and/or tissue expressiion pattern may be equally ef ective .

Since transformation of tobacco is more efficient than tomato, potential PR-Glucanase restorer genes were evaluated by retransformation of male sterile A9-PR Glucanase tobacco lines described in Worrall et al ( (1992) supra) . A full-length antisense PR-Glucanase gene was constructed as follows:- The PR-glucanase gene from pDWΘOPR was recloned as a Xbal, Sstll fragment into Xbal , Sstl l - cut pBluescript SK- forming pWP158. The PR glucanase gene was then recovered from pWPl58 as a EcoRI , Sstl l fragment and cloned between the Sstl l and .EcoRI sites of pWP80 (see WO-A-92/11379) forming pWP162. The A9 driven PR-Glucanase antisense gene was recovered from pWP162 as a SstI, EcoRV fragment and cloned between the

SstI and Smal sites of the binary vector pGPTV-Hpt

(Becker et al , Plant Molecular Biology, 20: 1195-1197 (1992)) , forming pWP162-Hpt. Of 51 tobacco PR-Glucanase plants transformed with pWP162-hpt 1 appeared to have increased callose levels and almost wild-type pollen production. This plant had 8 copies of the restorer gene.

Further antisense and partial sense PR-Glucanase constructs were constructed in an attempt to improve the frequency of restoration and to obtain plants that were restored to fertility by the presence of a single copy of the restorer gene, . Thus the following primers were designed in order to obtain by PCR different fragments of the PR-Glucanase gene: -

5' TCTAGACCATGGCTGCTATCACACTCCTAGG 3' N-term (l-31bp in Figure 5)

5' GGAACATGCAAGATGGTGGG 3 '

PRI (275-294 bp) 5' CCCTGTGATGGTGGATAAGAGC 3 ' PR2 (520-499 bp) 5' GGCAGCATACACAGAATCCAGC 3'

PR3 (749-728 bp) Ξ' CCGCGGTCACCCAAAGTTGATATTATATTTGA 3' C-term

(1028-997 bp)

Five PCR products were generated and cloned into the vector pGEM-T (Promega) , forming plasmids pJSHl to pJSH5. The PR-glucanase fragments were then cloned in the sense or antisense orientation behind the A9 promoter as outlined in figure 6, then transferred into the binary vector pSCV Nos-Hyg (this binary vector is a derivative of pSCVl (Firek et al , Plant Molecular Biology, 22:129-142 (1993)) which contains a nos promoter driving a hygromycin resistance gene, cloned between the EcoRV and EcoRI sites of pSCVl) .

The antisense and partial sense constructs were then used to transform a male-sterile tobacco PR-Glucanase line, and the level of PR-Glucanase expression in anthers assessed using an antibody raised against a tomato acidic β-1, 3-Glucanase gene. Results shown in figure 6 suggest that most of the restorer genes are capable of downregulating expression of PR-Glucanase, the most effective being pJSHlA-SCV with 15% of the retransformed plants lacking detectable PR-Glucanase. These restored plants exhibited normal or near normal male fertility. Analysis of progeny of restored plants containing a single copy of the restorer gene showed that restoration segregated with the restorer gene (Figure 7) and that the restoration gene was effective in down regulating PR-glucanase expression when transferred into a different A9-PR glucanase line, ie to demonstrate that down regulation by the restorer was only due to the restorer gene, a segregant carrying only the restorer gene was crossed into a a different A9-PR^' glucanase line. Again, the restorer gene was effective in down regulating PR- giucanase expression.

EXAMPLE 4: Restoration of male fertility in tomato plants containing the A9-PR Glucanase gene usinσ antisense directed against PR- Glucanase

The most effective A9-antisense restorer gene identified, that from pJSHIA, was transferred into a modified version of the binary vector pGA492 for use in tomato transformation. This binary vector, pBIOS222, is designed so that the selectable marker gene (pnos-nptll) can be removed after transformation. The pnos-nptll gene is cloned as a Ds element into pGA492 so that when crossed into a plant expressing Ac transposase, a proportion of the progeny lack the Ds : : pnos nptll element but retain the restorer gene . The Ac transposase tomato line is constructed by transformation of tomatoes with pBI0S144 (Figure 8a) . This is a derivative of pBI 35Ac (Finnegan et al , Plant Molecular Biology, 22:625-633 (1993) ) . The A9-antisense PR- Glucanase gene was excised from pJSHIA as an X ol, Bglll fragment and cloned between the Xhol and Bglll sites of pBIOS222 forming pBIOS 244 (Figure 8b) .

Tomato plants were transformed with pBI0Ξ244 and then crossed to tomato plants expressing Ac transposase. These plants were crossed to wild-type. Progeny of this cross, containing the A9-antisense PR Glucanase gene but lacking the Ds::nptII element and transposase, were bred to ho ozyosity and crossed to male sterile A9-PR Glucanase tomato plants. The hybrid progeny of this cross is 100% male fertile. EXAMPLE 5 : Restoration of male fertility to tomato plants containing the A9-PR Glucanase gene using partial sense directed against PR- Glucanase

An effective A9 partial sense restorer gene from pJSH5S was transferred into the binary vector pBI0S222 for use in tomato transformation. The A9-partial sense PR Glucanase gene was excised from pJSH5S as an Xhol , Bglll fragment and cloned between the Xhol and Bglll sites of pBI0S222 forming pBIOS222/5S (Figure 8c) .

Tomato plants were transformed with pBIOS222/5S and then crossed to BI0S144 tomato plants expressing Ac transposase. These plants were crossed to wild-type. Progeny of this cross, containing the A9-partial sense PR Glucanase gene but lacking the Ds: :nptII element and transposase, were bred to homozyosity and crossed to male sterile A9-PR Glucanase tomato plants. The hybrid progeny of this cross is 100% male fertile.

EXAMPLE 6: Evaluation of a male fertility restoration gene in tobacco:- A9 promoter anti PR-Glucanase multimeric ribozyme chimaeric gene

A multimeric ribozyme (Figure 9) , consisting of 4 standard hammerhead ribozymes each with flanking arms of 10 bases, was designed specifically to cleave the PR- Glucanase mRNA at 4 distinct target sites (Figure 5) . The multimeric ribozyme gene was constructed as follows : - Overlapping oligonucleotides were annealed to each other and extended by Sequenase (United States Biochemical ) . Adjoining bases were ligated with T4-DNA ligase. The final product was then amplified by PCR from the ligation mixture and cloned as a 198bp EcoRI, BamHI fragment into pBluescript (SK+) digested with EcoRI and BamHI.

Sequence analysis revealed a deletion of an adenosine residue at position 15 of the catalytic sequence of ribozyme 4, preventing the in vi tro activity of this ribozyme unit (Figure 10) . In vitro cleavage experiments show however that the other three ribozyme units of this multimeric ribozyme will cleave PR- glucanase message at 22°C (Figure 10) .

The 198bp multimeric ribozyme was cloned as a EcoRI (rendered blunt) , BamHI fragment between the Xbal (rendered blunt) , BamHI sites of pl415 (this is a derivative of pWP91 described in WO-A-92/11379) , in which an 8 bp Hindlll linker has been inserted into the EcoRV site) . The resulting A9 promoter driven multimeric ribozyme gene was then cloned as a Hindlll fragment into the Hindlll site of the binary vector pGA-3-HyB forming p3039 (Figure lla) . pGA-3-HyB contains a 35SCaMV- hygromycin resistance gene cloned between the SstI and

EcoRI sites of pGA492.

p3039 was then transformed into a male sterile A9 PR-Glucanase tobacco line. The presence of PR-Glucanase protein in anthers was determined by Western blot analysis and the male fertility of transformants assessed. 5 plants of 38 transformants exhibited improved male fertility and lacked PR-Glucanase protein. Analysis of the progeny showed that plants containing both the A9-PR Glucanase gene and the A9-multimeric ribozyme gene lacked PR-Glucanase protein (Figure 12) . EXAMPLE 7: Restoration of male fertility to tomato plants containing the A9-PR Glucanase gene using a multimeric ribozyme directed against PR- Glucanase

The A9- multimeric ribozyme gene of p3039 was excised as a Hindlll fragment and cloned into the Hindlll site of pBIOS222 forming pBIOS246 (Figure lib) . Tomato plants were transformed with pBIOS246 and then crossed to tomato plants expressing transposase. These plants were crossed to wild-type. Progeny of this cross, containing the A9-multimeric ribozyme gene but lacking the Ds: :πptII element and Ac transposase, were bred to homozyosity and crossed to male sterile A9-PR glucanase plants. The hybrid progeny of this cross is 100% male fertile.

Claims

CLAIMS :

1. The use of :

(i) a DNA sequence comprising the coding sequence of a glucanase enzyme;

operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence with appropriate tissue and/or temporal specificity, in the preparation of a male sterile transgenic tomato plant .

2. The use as claimed in claim 1 wherein the DNA sequence is operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence in the tapetum and/or microsporogenous cells prior to expression of callase .

3. The use as claimed in claim 2 wherein the DNA sequence is operably linked to a tapetum specific promoter.

4. The use as claimed in claim 3 wherein the tapetum specific promoter is an A3 or A9 promoter.

5. The use as claimed in claim 4 wherein the tapetum specific promoter s an A9 promoter

6. The use as claimed in claim 4 or claim 5 wherein the A3 or A9 promoter is the complete promoter.

7. The use as claimed in any one of claims 4 to 6 wherein the A3 or A9 promoter is derived from Brassicaceae .

8. The use as claimed any one of claims 1 to 3 wherein the promoter, or other regulatory sequence, comprises one or more temporal and/or tissue control sequences derived from a tapetum specific promoter.

9. The use as claimed claim 8 wherein the temporal and/or tissue control sequences are derived from an A3 or A9 promoter.

10. The use as claimed in claimed in any one of claims 1 to 9 wherein the glucanase is β (1, 3) PR-Glucanase.

11. The use as claimed in claim 10 wherein the DNA sequence coding for PR-Glucanase is as shown in figure 5.

12. The use as claimed in any one of claims 1 to 11 wherein the DNA sequence forms at least part of a vector.

13. A DNA sequence which is complementary to at least a part of a DNA sequence coding for a glucanase as defined in (ι) , (n) or (m) of claim 1.

14 A DNA sequence as claimed n claim 13 which is operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence with appropriate tissue and/or temporal specificity.

15. A DNA sequence as claimed in claim 14 which is operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence in the tapetum and/or microsporogenous cells prior to expression of callase.

16. A DNA sequence as claimed in claim 15 wherein the promoter is a tapetum specific promoter.

17. A DNA sequence as claimed in claim 16 wherein the tapetum specific promoter is an A3 or A9 promoter.

18. A DNA sequence as claimed in claim 17 wherein the tapetum specific promoter is an A9 promoter.

19. A DNA sequence as claimed in any one of claims 13 to 18 wherein the complementary DNA sequence is complementary to at least a part of the DNA sequence coding for β (1, 3) PR-Glucanase.

20. A DNA sequence as claimed in claim 19 wherein the complementary DNA sequence is complementary to at least a part of the sequence shown in figure 5.

21. A DNA sequence encoding a ribozyme capable of specific cleavage of RNA encoded by a DNA sequence as defined in (i) , (ii) or (iii) of claim 1.

22. A DNA sequence as claimed in claim 21 which is operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence with appropriate tissue and/or temporal specificity

23. A DNA sequence as claimed in claim 22 which is operably linked to a promoter, or other regulatory sequence, which provides for expression of the DNA sequence in the tapetum and/or microsporogenous cells prior to expression of callase.

24. A DNA sequence as claimed in claim 23 modified by any one or more of the features of claims 15 to 18.

25. A DNA sequence as claimed any one of claims 21 to 24 wherein the ribozyme is capable of specific cleavage of RNA encoded by the DNA sequence for PR- Glucanase.

26. A DNA sequence as claimed claim 25 wherein the DNA sequence coding for the ribozyme has the sequence shown in figure 9.

27. The use of a DNA sequence as defined in any one of claims 13 to 26 in restoring male-fertility in a tomato plant .

28. A transgenic tomato plant which has incorporated n at least some of its cells a DNA sequence as defined any one of claims 1 to 12.

29. A transgenic tomato plant which has incorporated at least some of its cells a DNA sequence as defined in any one of claims 13 to 26.

30. A plant cell including a DNA sequence as defined in any one of claims 1 to 12.

31. A plant cell including a DNA sequence as defined m any one of claims 13 to 26.

32. Propagating material derived from a plant as defined in claim 28 or claim 29.

33. Seeds obtainable from a transgenic tomato plant as defined in claim 28 or claim 29.

34. A method for restoring male fertility in a male- sterile tomato plant which comprises :

(i) producing a transgenic tomato plant as defined in claim 29; and

(ii) crossing the transgenic tomato plant produced in step (i) with a transgenic tomato plant as defined in claim 28.